Location History:
- Basel, CH (1986)
- Zurich, CH (2000 - 2010)
Company Filing History:
Years Active: 1986-2010
Title: The Innovations of Ernst Kupfer
Introduction
Ernst Kupfer is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of biocatalysis and ligand chemistry. With a total of five patents to his name, Kupfer's work has advanced the development of key intermediates in pharmaceutical manufacturing.
Latest Patents
One of Kupfer's latest patents focuses on biocatalytic asymmetric reduction in the preparation of (S)-N-[5-(1,2-dihydroxy-ethyl)-pyrazinyl]-2,2-dimethyl-propionamide. This invention relates to the biocatalytic asymmetric reduction for the preparation of 2-amino-[5-(1-hydroxy-2-hydroxy or halogen-ethyl)]-pyrazine derivatives. The compounds produced are essential intermediates in the manufacture of a glucokinase activator. Another significant patent involves new phosphine ligands, which are crucial in various chemical applications.
Career Highlights
Kupfer has built a distinguished career at Hoffmann-La Roche Inc., where he has been instrumental in various innovative projects. His expertise in biocatalysis and ligand chemistry has positioned him as a key player in the pharmaceutical industry.
Collaborations
Throughout his career, Kupfer has collaborated with talented individuals such as Stephan Doswald and Steven Paul Hanlon. These partnerships have fostered a creative environment that has led to groundbreaking advancements in their respective fields.
Conclusion
Ernst Kupfer's contributions to innovation in biocatalysis and ligand chemistry are noteworthy. His patents reflect a commitment to advancing pharmaceutical science and improving drug development processes. His work continues to influence the industry and inspire future innovations.